Epithelioid malignant mesothelioma is a rare but deadly form of cancer that affects the mesothelial cells that line the lungs, heart, and other organs in the body. It is caused by exposure to asbestos, a naturally occurring mineral fiber that is used in a variety of construction materials. While the risk of developing this cancer is extremely low, those who have been exposed to asbestos are at an increased risk.
The symptoms of epithelioid malignant mesothelioma can mimic other more common conditions, making it difficult to diagnose. Common symptoms include chest pain, coughing, shortness of breath, and difficulty breathing. In some cases, the cancer may spread to other parts of the body, such as the abdomen or the lymph nodes.
Treatment for epithelioid malignant mesothelioma usually includes a combination of surgery, radiation therapy, and chemotherapy. Surgery is the most common form of treatment and can involve removing the cancerous tissue from the affected area. Radiation therapy can be used to shrink the tumor and chemotherapy can help to kill the cancerous cells.
Unfortunately, epithelioid malignant mesothelioma is a very aggressive form of cancer and it is often not curable. The average survival rate for those diagnosed with this cancer is between 3 and 5 years. However, with early detection and treatment, some patients may be able to extend their life expectancy.
Epithelioid malignant mesothelioma is a very serious form of cancer that can have a devastating impact on a person’s life. It is important for those who have been exposed to asbestos to be aware of the potential health risks and to get regular medical screenings. Early diagnosis and treatment can help to improve the chances of survival and quality of life for those diagnosed with this rare but deadly form of cancer.